Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glial Cells01:04

Glial Cells

96.4K
Overview
96.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR Trial.

Neuro-oncology·2026
Same author

2025 Advancing Cell and Gene Therapies for Cancer post-meeting report.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

HSR26-206: The Future of Oncology Research: Replacing Case Report Forms With mCODE-Aligned Electronic Health Record Data for Clinical Trial Data Curation (Alliance).

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, <i>IDH</i>-wildtype.

Neuro-oncology advances·2026
Same author

HSR26-206: The Future of Oncology Research: Replacing Case Report Forms With mCODE-Aligned Electronic Health Record Data for Clinical Trial Data Curation (Alliance).

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Preface.

Handbook of clinical neurology·2026
Same journal

Foreword.

Handbook of clinical neurology·2026
Same journal

Fundus autofluorescence imaging.

Handbook of clinical neurology·2026
Same journal

The electroretinogram as a means to study the physiology of the retina.

Handbook of clinical neurology·2026
Same journal

Adaptive optics scanning light ophthalmoscopy.

Handbook of clinical neurology·2026
Same journal

Modeling the human retina in a dish: Advances and future directions.

Handbook of clinical neurology·2026
See all related articles

Related Experiment Video

Updated: Mar 24, 2026

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.6K

Glioblastoma.

Hans-Georg Wirsching1, Evanthia Galanis2, Michael Weller1

  • 1Department of Neurology, University Hospital Zurich, Zurich, Switzerland.

Handbook of Clinical Neurology
|March 8, 2016
PubMed
Summary
This summary is machine-generated.

Glioblastoma, an aggressive brain tumor, is classified by specific features and molecular changes. Treatment involves surgery, radiation, and chemotherapy, with O(6)-methylguanyl DNA methyltransferase (MGMT) promoter methylation guiding therapy.

Keywords:
angiogenesisglioblastomaglioma-initiating cellimmunotherapymolecular subtyperadiotherapytemozolomide

More Related Videos

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.7K
Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.9K

Related Experiment Videos

Last Updated: Mar 24, 2026

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.6K
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.7K
Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.9K

Area of Science:

  • Neuro-oncology
  • Molecular pathology
  • Cancer biology

Background:

  • Glioblastoma is the most aggressive primary adult brain tumor, WHO grade IV.
  • Characterized by necrosis and endothelial proliferation.
  • Secondary glioblastoma evolves from lower-grade gliomas.

Purpose of the Study:

  • To define the histopathologic and molecular features of glioblastoma.
  • To outline current treatment strategies and emerging therapeutic targets.
  • To discuss the role of molecular markers in glioblastoma classification and treatment.

Main Methods:

  • Histopathologic analysis for necrosis and endothelial proliferation.
  • Molecular profiling for IDH mutations, RTK/RAS/PI3K, p53, and RB signaling.
  • Assessment of O(6)-methylguanyl DNA methyltransferase (MGMT) promoter methylation.

Main Results:

  • IDH mutations define a subset of glioblastomas with younger age and better prognosis.
  • Glioblastomas typically exhibit mutations in RTK/RAS/PI3K, p53, and RB pathways.
  • MGMT promoter methylation predicts response to alkylating chemotherapy (temozolomide).

Conclusions:

  • Glioblastoma classification relies on histopathology and molecular markers like IDH and MGMT.
  • Standard treatments include surgery, radiotherapy, and chemotherapy.
  • Future directions involve targeting molecular pathways and immunotherapy.